Übermittlung einer Datenschutzverletzungsmeldung der Europäischen Arzneimittel-Agentur an das Paul-Ehrlich-Institut

This procedure concerns a written question regarding a data breach notification sent by the European Medicines Agency (EMA) to Germany's Paul-Ehrlich-Institut. It aims to clarify the details of the security incident and how information was handled. German authorities and pharmaceutical regulatory bodies are affected by this inquiry, which seeks transparency regarding data protection compliance and the management of sensitive information within European health agencies.